You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Chile Patent: 2007002242


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2007002242

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
⤷  Get Started Free Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
⤷  Get Started Free Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
⤷  Get Started Free Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
⤷  Get Started Free Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Patent CL2007002242

Last updated: July 28, 2025


Introduction

The patent CL2007002242, granted in Chile, pertains to a specific pharmaceutical invention. This analysis offers a comprehensive examination of the patent’s scope, claims, and its positioning within the broader patent landscape. The goal is to inform stakeholders—pharmaceutical companies, legal practitioners, and R&D strategists—on the patent’s enforceability, potential for infringement, and strategic relevance in the evolving Chilean and global patent contexts.


Patent Overview

Patent Number: CL2007002242
Filing Date: Likely 2007 (based on serial number)
Grant Date: To be verified through Chilean patent office records
Applicant/Inventor: To be confirmed through official documentation

This patent appears to focus on a novel aspect of a drug compound, formulation, process, or use—common in pharmaceuticals. The scope and claims define the legal boundaries, determining the extent of protection and potential for licensing or litigation.


Scope of the Patent

Legal Scope and Commercial Significance

The scope refers to the extent of what the patent protects—whether it covers specific compounds, manufacturing methods, therapeutic indications, or combinations thereof. For pharmaceutical patents, the scope is often delineated by:

  • Compound Claims: Protecting a specific chemical entity or a family of molecules.
  • Method Claims: Covering particular synthesis or formulation techniques.
  • Use Claims: Covering therapeutic applications or indications.

In CL2007002242, the scope hinges on the language of the patent claims. Chilean patents typically employ broad or narrow claims, contingent upon the applicant’s strategic goals and patent examination.

Assessment of Claim Breadth:

  • Independent Claims: Typically encompass the core inventive element—e.g., a chemical structure or a method of treatment.
  • Dependent Claims: Refine or narrow the scope—e.g., specify particular substituents or dosage forms.

The patent’s linguistic framing influences enforceability. Broad claims increase market protection but are more susceptible to invalidation for lack of novelty or inventive step. Narrow claims tend to be more robust but limit coverage.


Claims Analysis

1. Chemical Compound Claims

If the patent covers a specific chemical entity, the claims define the molecular structure(s), often by chemical formulae and substituents. The claims might include:

  • Structural Formulae: Precise chemical structures.
  • Pharmacophoric Features: Functional groups critical for activity.
  • Isomers or Derivatives: Variations of the core compound.

2. Process Claims

These cover unique synthetic routes or manufacturing methods. Process patents are especially valuable if they improve yields, purity, or reduce costs.

3. Use or Therapeutic Method Claims

Claims may specify particular medical indications, expanding protection via 'use patents'—common in pharmaceutics.

Claim Validity Factors:

  • Novelty: The claimed compound or method must be new.
  • Inventive Step: Must differ sufficiently from prior art.
  • Industrial Applicability: Practical use in manufacturing or treatment.

Potential Overlaps and Prior Art Risks:

  • Prior Art Search: Essential to establish novelty. Similar compounds or methods in existing patents or publications could narrow or invalidate claims.
  • Patent Thickets: Cross-referenced or overlapping patents in the same chemical core may complicate freedom-to-operate.

Patent Landscape in Chile

1. Chile’s Patent System for Pharmaceuticals

Chile’s patent law aligns broadly with international standards (e.g., TRIPS Agreement). It provides 20-year protections from the filing date, subject to maintenance fees. Chile classifies patents via the International Patent Classification (IPC), with biotechnological and chemical innovations categorized accordingly.

2. Key Patent Families and Overlapping Patent Rights

Within the Chilean landscape, pharmaceutical patents often cluster around:

  • Active Pharmaceutical Ingredient (API) Patents: Protecting specific molecules.
  • Formulation Patents: Covering specific compositions.
  • Method Patents: Covering therapeutic uses.

It’s common for multiple patents to serve different strategic purposes—blocking compositions and protecting methods separately.

3. Related International Patents and Families

Patent CL2007002242 may belong to an international patent family filed via PCT, USPTO, EPO, or others. Cross-referencing these patents reveals potential overlapping rights and freedom-to-operate considerations.


Strategic Positioning and Implications

1. Patent Strength and Defensive Portfolio

The scope—assuming broad claims—can solidify market exclusivity within Chile, provided they withstand validity challenges. Narrow claims restrict protection but can be easier to defend.

2. Potential for Infringement and Litigation

Infringement risks arise if competitors develop similar compounds or formulations. The patent’s claims’ wording and scope dictate enforcement strategies.

3. Challenges and Limitations

  • Claim Enforceability: Chilean courts interpret claims based on the patent language and prior art.
  • Post-Grant Challenges: Validity can be contested based on prior art or patentability grounds, influencing strategic decisions.

4. International Considerations

Given Chile’s accession to various international treaties, patent rights within Chile can interface with global rights—particularly if the patent is part of a broader portfolio.


Conclusion

The Chilean patent CL2007002242 potentially grants significant protection for an innovative pharmaceutical compound, process, or use. The exact scope is defined by its claims, which likely include one or more independent claims with narrower dependent claims. Its strategic value hinges on claim breadth, prior art landscape, and potential for infringement.

For stakeholders, ongoing monitoring of Chilean patent filings, validity challenges, and international patent family proliferation is essential to optimize R&D investments and ensure freedom to operate within Chile.


Key Takeaways

  • The scope and claims define the enforceability and market exclusivity for the patented drug in Chile.
  • Broad claims increase strategic value but face higher invalidation risks; narrow claims are more defensible.
  • The patent landscape in Chile is aligned with international standards, but local nuances and prior art influence patent validity.
  • Ongoing patent monitoring, especially of related international filings, enhances strategic positioning.
  • Building a robust patent portfolio requires integrating claims from Chile and international filings, considering local legal interpretations.

FAQs

1. How can I assess whether Patent CL2007002242 is valid in Chile?
A comprehensive validity assessment involves analyzing the patent claims against prior art local and international references, assessing novelty, inventive step, and sufficiency of disclosure. Engage patent attorneys or IP specialists for a detailed validity opinion.

2. What is the strategic importance of claims breadth in this patent?
Broader claims can provide wider protection against competitors but are more prone to invalidation; narrower claims are easier to defend but limit the scope of protection.

3. Are method claims in this patent enforceable in Chile?
Method claims are enforceable if upheld during litigation and valid under Chilean patent law. The enforceability depends on the specific wording and prior art considerations.

4. How does this patent relate to international patent filings?
If filed via PCT or in key jurisdictions, the patent family may extend protection beyond Chile, impacting global freedom-to-operate and licensing strategies.

5. What potential challenges could this patent face in Chile?
Challenges include invalidation due to prior art, lack of inventive step, or insufficiency of disclosure. Regular monitoring, legal audits, and strategic patent drafting mitigate these risks.


References

  1. Chilean Patent Law, Law No. 19,039.
  2. World Intellectual Property Organization. International Patent Classification (IPC).
  3. Chilean National Institute of Industrial Property (INAPI). Patent database records.
  4. TRIPS Agreement, WTO.
  5. Global Patent Landscape Reports, WIPO.

Note: Specific patent document details, such as filing date, inventor, and claims, should be verified via official INAPI resources for precise analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.